Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.
Nougarede, Adrien
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10. [electronic resource] - Cancer research 03 2018 - 1404-1417 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-7445
10.1158/0008-5472.CAN-17-0846 doi
Animals
Apoptosis--drug effects
Binding Sites
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Calcium--metabolism
Cell Line, Tumor
Drug Resistance, Neoplasm
Endoplasmic Reticulum--drug effects
Female
Humans
Inositol 1,4,5-Trisphosphate Receptors--metabolism
Mice, SCID
Molecular Targeted Therapy--methods
Peptide Fragments--metabolism
Peptides--pharmacology
Prognosis
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors
Xenograft Model Antitumor Assays
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10. [electronic resource] - Cancer research 03 2018 - 1404-1417 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-7445
10.1158/0008-5472.CAN-17-0846 doi
Animals
Apoptosis--drug effects
Binding Sites
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Calcium--metabolism
Cell Line, Tumor
Drug Resistance, Neoplasm
Endoplasmic Reticulum--drug effects
Female
Humans
Inositol 1,4,5-Trisphosphate Receptors--metabolism
Mice, SCID
Molecular Targeted Therapy--methods
Peptide Fragments--metabolism
Peptides--pharmacology
Prognosis
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors
Xenograft Model Antitumor Assays